Ratings by Wedbush (Laura Chico)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/5/2026 | Climb Bio | CLYM | New Coverage | Outperform (N/A) |
7.28 (7.18) |
-1.37% | Details | |
| 3/3/2026 | Larimar Therapeutics | LRMR | Maintain | Outperform (N/A) |
|
Details | ||
| 2/20/2026 | Praxis Precision Medicines Inc. | PRAX | Maintain | Underperform (N/A) |
|
Details | ||
| 1/12/2026 | Stoke Therapeutics | STOK | Maintain | Outperform (N/A) |
|
Details | ||
| 12/10/2025 | Viridian Therapeutic | VRDN | Maintain | Outperform (N/A) |
|
Details | ||
| 11/6/2025 | Edgewise Therapeutics | EWTX | Maintain | Outperform (N/A) |
|
Details | ||
| 10/15/2025 | Astria Therapeutics | ATXS | Downgrade | Neutral (Outperform) |
11.61 (12.58) |
8.35% | Details | |
| 10/3/2025 | Ovid Therapeutics Inc | OVID | Maintain | Outperform (N/A) |
|
Details | ||
| 9/12/2025 | Dianthus Therapeutics | DNTH | Maintain | Outperform (N/A) |
|
Details | ||
| 9/9/2025 | Tourmaline Bio | TRML | Downgrade | Neutral (Outperform) |
30.18 (47.98) |
58.98% | Details | |
| 8/14/2025 | Jade Biosciences | JBIO | Maintain | Outperform (N/A) |
|
Details | ||
| 8/13/2025 | Solid Biosciences | SLDB | Maintain | Outperform (N/A) |
|
Details | ||
| 8/5/2025 | Ardelyx, Inc | ARDX | Maintain | Outperform (N/A) |
|
Details | ||
| 8/4/2025 | Praxis Precision Medicines Inc. | PRAX | Maintain | Underperform (N/A) |
|
Details | ||
| 7/31/2025 | Neurocrine Bio. | NBIX | Maintain | Outperform (N/A) |
|
Details | ||
| 6/30/2025 | BioCryst Pharma | BCRX | Maintain | Outperform (N/A) |
|
Details | ||
| 6/24/2025 | Larimar Therapeutics | LRMR | Maintain | Outperform (N/A) |
|
Details | ||
| 6/16/2025 | Sage Therapeutics | SAGE | Maintain | Neutral (N/A) |
|
Details | ||
| 6/9/2025 | Vera Therapeutics | VERA | Maintain | Neutral (N/A) |
|
Details | ||
| 5/22/2025 | Vigil Neuroscience Inc | VIGL | Downgrade | Neutral (Outperform) |
2.31 (8.05) |
248.48% | Details | |
| 5/16/2025 | Solid Biosciences | SLDB | Maintain | Outperform (N/A) |
|
Details | ||
| 5/14/2025 | Pharvaris B.V. | PHVS | Maintain | Outperform (N/A) |
|
Details | ||
| 5/7/2025 | Jade Biosciences | JBIO | New Coverage | Outperform (N/A) |
10.09 (14.05) |
39.25% | Details | |
| 5/7/2025 | Denali Therapeutics Inc. | DNLI | Maintain | Outperform (N/A) |
|
Details | ||
| 5/6/2025 | Neurocrine Bio. | NBIX | Maintain | Outperform (N/A) |
|
Details | ||
| 4/16/2025 | Neurocrine Bio. | NBIX | Maintain | Outperform (N/A) |
|
Details | ||
| 4/16/2025 | Ultragenyx Pharma | RARE | Maintain | Neutral (N/A) |
|
Details | ||
| 4/16/2025 | Biogen | BIIB | Maintain | Neutral (N/A) |
|
Details | ||
| 4/16/2025 | Apellis Pharmaceuticals | APLS | Maintain | Neutral (N/A) |
|
Details | ||
| 3/24/2025 | Larimar Therapeutics | LRMR | Maintain | Outperform (N/A) |
|
Details | ||
| 3/14/2025 | Tourmaline Bio | TRML | Maintain | Outperform (N/A) |
|
Details | ||
| 3/12/2025 | Ovid Therapeutics Inc | OVID | Maintain | Outperform (N/A) |
|
Details | ||
| 3/12/2025 | Astria Therapeutics | ATXS | Maintain | Outperform (N/A) |
|
Details | ||
| 3/6/2025 | Tourmaline Bio | TRML | New Coverage | Outperform (N/A) |
12.90 (30.18) |
133.95% | Details | |
| 3/3/2025 | Apellis Pharmaceuticals | APLS | Maintain | Neutral (N/A) |
|
Details | ||
| 2/28/2025 | Praxis Precision Medicines Inc. | PRAX | Downgrade | Underperform (Neutral) |
65.03 (310.71) |
377.79% | Details | |
| 2/25/2025 | BioCryst Pharma | BCRX | New Coverage | Outperform (N/A) |
8.29 (8.48) |
2.29% | Details | |
| 2/13/2025 | Biogen | BIIB | Maintain | Neutral (N/A) |
|
Details | ||
| 2/7/2025 | Neurocrine Bio. | NBIX | Maintain | Outperform (N/A) |
|
Details | ||
| 1/23/2025 | Sage Therapeutics | SAGE | Maintain | Neutral (N/A) |
|
Details | ||
| 1/23/2025 | Ultragenyx Pharma | RARE | Maintain | Neutral (N/A) |
|
Details | ||
| 1/23/2025 | Biogen | BIIB | Maintain | Neutral (N/A) |
|
Details | ||
| 1/23/2025 | Apellis Pharmaceuticals | APLS | Maintain | Neutral (N/A) |
|
Details | ||
| 1/23/2025 | Xenon Pharmaceuticals | XENE | Maintain | Outperform (N/A) |
|
Details | ||
| 1/23/2025 | Travere Therapeutics | TVTX | Maintain | Outperform (N/A) |
|
Details | ||
| 1/23/2025 | Neurocrine Bio. | NBIX | Maintain | Outperform (N/A) |
|
Details | ||
| 12/13/2024 | Solid Biosciences | SLDB | New Coverage | Outperform (N/A) |
5.01 (6.75) |
34.73% | Details | |
| 11/13/2024 | Xenon Pharmaceuticals | XENE | Maintain | Outperform (N/A) |
|
Details | ||
| 11/6/2024 | Ultragenyx Pharma | RARE | Maintain | Neutral (N/A) |
|
Details | ||
| 10/23/2024 | Alto Neuroscience | ANRO | Downgrade | Neutral (Outperform) |
14.53 (20.76) |
42.88% | Details | |
| 10/14/2024 | Longboard Pharmaceuticals Inc | LBPH | Downgrade | Neutral (Outperform) |
38.90 (59.98) |
54.19% | Details | |
| 10/3/2024 | Larimar Therapeutics | LRMR | New Coverage | Outperform (N/A) |
6.29 (5.22) |
-17.01% | Details | |
| 9/27/2024 | Travere Therapeutics | TVTX | Maintain | Outperform (N/A) |
|
Details | ||
| 9/23/2024 | Biogen | BIIB | Maintain | Neutral (N/A) |
|
Details | ||
| 9/19/2024 | Edgewise Therapeutics | EWTX | Maintain | Outperform (N/A) |
|
Details | ||
| 9/6/2024 | Travere Therapeutics | TVTX | Maintain | Outperform (N/A) |
|
Details | ||
| 9/3/2024 | Denali Therapeutics Inc. | DNLI | Maintain | Outperform (N/A) |
|
Details | ||
| 9/3/2024 | Praxis Precision Medicines Inc. | PRAX | Maintain | Neutral (N/A) |
|
Details | ||
| 9/3/2024 | Alto Neuroscience | ANRO | New Coverage | Outperform (N/A) |
12.81 (20.76) |
62.06% | Details | |
| 8/14/2024 | Praxis Precision Medicines Inc. | PRAX | Maintain | Neutral (N/A) |
|
Details | ||
| 8/12/2024 | Apellis Pharmaceuticals | APLS | Maintain | Neutral (N/A) |
|
Details | ||
| 8/12/2024 | Xenon Pharmaceuticals | XENE | Maintain | Outperform (N/A) |
|
Details | ||
| 8/7/2024 | Voyager Therapeutics | VYGR | Maintain | Neutral (N/A) |
|
Details | ||
| 8/2/2024 | Travere Therapeutics | TVTX | Maintain | Outperform (N/A) |
|
Details | ||
| 8/1/2024 | Neurocrine Bio. | NBIX | Maintain | Outperform (N/A) |
|
Details | ||
| 7/2/2024 | Ardelyx, Inc | ARDX | Maintain | Outperform (N/A) |
|
Details | ||
| 6/27/2024 | Vigil Neuroscience Inc | VIGL | Maintain | Outperform (N/A) |
|
Details | ||
| 6/10/2024 | Longboard Pharmaceuticals Inc | LBPH | Maintain | Outperform (N/A) |
|
Details | ||
| 5/31/2024 | Ultragenyx Pharma | RARE | Maintain | Neutral (N/A) |
|
Details | ||
| 5/14/2024 | Voyager Therapeutics | VYGR | Maintain | Neutral (N/A) |
|
Details | ||
| 5/10/2024 | Xenon Pharmaceuticals | XENE | Maintain | Outperform (N/A) |
|
Details | ||
| 5/10/2024 | Dianthus Therapeutics | DNTH | Maintain | Outperform (N/A) |
|
Details | ||
| 5/9/2024 | Pharvaris B.V. | PHVS | Maintain | Outperform (N/A) |
|
Details | ||
| 5/8/2024 | Denali Therapeutics Inc. | DNLI | Maintain | Outperform (N/A) |
|
Details | ||
| 5/3/2024 | Longboard Pharmaceuticals Inc | LBPH | Maintain | Outperform (N/A) |
|
Details | ||
| 4/24/2024 | Biogen | BIIB | Maintain | Neutral (N/A) |
|
Details | ||
| 4/11/2024 | Rallybio Corp. | RLYB | Maintain | Outperform (N/A) |
|
Details | ||
| 4/8/2024 | Praxis Precision Medicines Inc. | PRAX | Maintain | Neutral (N/A) |
|
Details | ||
| 4/5/2024 | Ovid Therapeutics Inc | OVID | New Coverage | Outperform (N/A) |
3.05 (1.91) |
-37.38% | Details | |
| 3/26/2024 | Astria Therapeutics | ATXS | Maintain | Outperform (N/A) |
|
Details | ||
| 3/26/2024 | Stoke Therapeutics | STOK | Maintain | Outperform (N/A) |
|
Details | ||
| 3/22/2024 | Dianthus Therapeutics | DNTH | Maintain | Outperform (N/A) |
|
Details | ||
| 3/21/2024 | Vera Therapeutics | VERA | Maintain | Outperform (N/A) |
|
Details | ||
| 3/5/2024 | Praxis Precision Medicines Inc. | PRAX | Maintain | Neutral (N/A) |
|
Details | ||
| 3/1/2024 | Xenon Pharmaceuticals | XENE | Maintain | Outperform (N/A) |
|
Details | ||
| 2/28/2024 | Apellis Pharmaceuticals | APLS | Maintain | Neutral (N/A) |
|
Details | ||
| 2/16/2024 | Ultragenyx Pharma | RARE | Maintain | Neutral (N/A) |
|
Details | ||
| 2/7/2024 | Rallybio Corp. | RLYB | Maintain | Outperform (N/A) |
|
Details | ||
| 1/29/2024 | Travere Therapeutics | TVTX | Maintain | Outperform (N/A) |
|
Details | ||
| 1/29/2024 | Sage Therapeutics | SAGE | Maintain | Neutral (N/A) |
|
Details | ||
| 1/29/2024 | Biogen | BIIB | Maintain | Neutral (N/A) |
|
Details | ||
| 1/29/2024 | Neurocrine Bio. | NBIX | Maintain | Outperform (N/A) |
|
Details | ||
| 1/22/2024 | Viridian Therapeutic | VRDN | Maintain | Outperform (N/A) |
|
Details | ||
| 1/12/2024 | Apellis Pharmaceuticals | APLS | Maintain | Neutral (N/A) |
|
Details | ||
| 1/12/2024 | Ardelyx, Inc | ARDX | Maintain | Outperform (N/A) |
|
Details | ||
| 1/8/2024 | Longboard Pharmaceuticals Inc | LBPH | Maintain | Outperform (N/A) |
|
Details | ||
| 12/22/2023 | Karuna Therapeutics Inc. | KRTX | Downgrade | Neutral (Outperform) |
215.19 (329.83) |
53.27% | Details | |
| 11/29/2023 | Praxis Precision Medicines Inc. | PRAX | Maintain | Neutral (N/A) |
|
Details | ||
| 11/22/2023 | Dianthus Therapeutics | DNTH | New Coverage | Outperform (N/A) |
11.50 (65.20) |
466.96% | Details | |
| 11/14/2023 | Design Therapeutics Inc | DSGN | Maintain | Neutral (N/A) |
|
Details | ||
| 11/10/2023 | Edgewise Therapeutics | EWTX | Maintain | Outperform (N/A) |
|
Details | ||
| 11/10/2023 | Rallybio Corp. | RLYB | Maintain | Outperform (N/A) |
|
Details | ||
| 11/9/2023 | Xenon Pharmaceuticals | XENE | Maintain | Outperform (N/A) |
|
Details | ||
| 11/8/2023 | PepGen Inc. | PEPG | Maintain | Outperform (N/A) |
|
Details | ||
| 10/26/2023 | Biogen | BIIB | Maintain | Neutral (N/A) |
|
Details | ||
| 10/13/2023 | Astria Therapeutics | ATXS | Maintain | Outperform (N/A) |
|
Details | ||
| 9/25/2023 | Pharvaris B.V. | PHVS | New Coverage | Outperform (N/A) |
20.32 (25.91) |
27.51% | Details | |
| 9/13/2023 | Neurocrine Bio. | NBIX | Maintain | Outperform (N/A) |
|
Details | ||
| 8/11/2023 | Vera Therapeutics | VERA | Maintain | Neutral (N/A) |
|
Details | ||
| 8/9/2023 | Denali Therapeutics Inc. | DNLI | Maintain | Outperform (N/A) |
|
Details | ||
| 8/8/2023 | Astria Therapeutics | ATXS | Maintain | Outperform (N/A) |
|
Details | ||
| 8/8/2023 | Chinook Therapeutics | KDNY | Downgrade | Neutral (Outperform) |
40.35 (40.39) |
0.1% | Details | |
| 8/7/2023 | Sage Therapeutics | SAGE | Downgrade | Neutral (N/A) |
36.10 (8.68) |
-75.96% | Details | |
| 8/7/2023 | Apellis Pharmaceuticals | APLS | Maintain | Neutral (N/A) |
|
Details | ||
| 7/31/2023 | Apellis Pharmaceuticals | APLS | Maintain | Neutral (N/A) |
|
Details | ||
| 7/26/2023 | Biogen | BIIB | Maintain | Neutral (N/A) |
|
Details | ||
| 7/20/2023 | Apellis Pharmaceuticals | APLS | Maintain | Neutral (N/A) |
|
Details | ||
| 5/10/2023 | Xenon Pharmaceuticals | XENE | Maintain | Outperform (N/A) |
|
Details | ||
| 4/10/2023 | Rallybio Corp. | RLYB | New Coverage | Outperform (N/A) |
4.91 (10.91) |
122.2% | Details | |
| 3/3/2023 | Ardelyx, Inc | ARDX | Upgrade | Outperform (Neutral) |
2.89 (6.19) |
114.19% | Details | |
| 2/21/2023 | Apellis Pharmaceuticals | APLS | Maintain | Neutral (N/A) |
|
Details | ||
| 2/21/2023 | Travere Therapeutics | TVTX | Upgrade | Outperform (Neutral) |
17.82 (27.24) |
52.86% | Details | |
| 2/17/2023 | Ultragenyx Pharma | RARE | Maintain | Neutral (N/A) |
|
Details | ||
| 2/6/2023 | Neurocrine Bio. | NBIX | Maintain | Outperform (N/A) |
|
Details | ||
| 1/4/2023 | Vera Therapeutics | VERA | Downgrade | Neutral (Outperform) |
18.30 (39.07) |
113.5% | Details | |
| 11/15/2022 | Impel Neuropharma | IMPL | Downgrade | Neutral (Outperform) |
3.36 (0.24) |
-92.86% | Details | |
| 11/9/2022 | Xenon Pharmaceuticals | XENE | Maintain | Outperform (N/A) |
|
Details | ||
| 11/8/2022 | Apellis Pharmaceuticals | APLS | Maintain | Neutral (N/A) |
|
Details | ||
| 11/3/2022 | Edgewise Therapeutics | EWTX | Maintain | Outperform (N/A) |
|
Details | ||
| 9/28/2022 | Biogen | BIIB | Maintain | Neutral (N/A) |
|
Details | ||
| 9/16/2022 | Vigil Neuroscience Inc | VIGL | New Coverage | Outperform (N/A) |
9.00 (8.05) |
-10.56% | Details | |
| 9/12/2022 | Apellis Pharmaceuticals | APLS | Maintain | Neutral (N/A) |
|
Details | ||
| 8/18/2022 | Viridian Therapeutic | VRDN | Maintain | Outperform (N/A) |
|
Details | ||
| 8/15/2022 | Impel Neuropharma | IMPL | Maintain | Outperform (N/A) |
|
Details | ||
| 8/10/2022 | Karuna Therapeutics Inc. | KRTX | Maintain | Outperform (N/A) |
|
Details | ||
| 8/10/2022 | Xenon Pharmaceuticals | XENE | Maintain | Outperform (N/A) |
|
Details | ||
| 8/8/2022 | Biohaven Pharmaceutical Holding | BHVN | Downgrade | Neutral (Outperform) |
146.98 (9.92) |
-93.25% | Details | |
| 7/14/2022 | Ultragenyx Pharma | RARE | Maintain | Neutral (N/A) |
|
Details | ||
| 6/27/2022 | Xenon Pharmaceuticals | XENE | Maintain | Outperform (N/A) |
|
Details | ||
| 6/6/2022 | Praxis Precision Medicines Inc. | PRAX | Downgrade | Neutral (Outperform) |
8.59 (310.71) |
3517.11% | Details | |
| 5/31/2022 | PepGen Inc. | PEPG | New Coverage | Outperform (N/A) |
10.88 (5.69) |
-47.7% | Details | |
| 5/23/2022 | Chinook Therapeutics | KDNY | Maintain | Outperform (N/A) |
|
Details | ||
| 5/13/2022 | Chinook Therapeutics | KDNY | Maintain | Outperform (N/A) |
|
Details | ||
| 5/3/2022 | Biogen | BIIB | Maintain | Neutral (N/A) |
|
Details | ||
| 4/19/2022 | Vera Therapeutics | VERA | New Coverage | Outperform (N/A) |
23.12 (39.07) |
68.99% | Details | |
| 3/31/2022 | Taysha Gene Therapies | TSHA | Maintain | Outperform (N/A) |
|
Details | ||
| 3/24/2022 | Aptinyx | APTX | Maintain | Outperform (N/A) |
|
Details | ||
| 3/8/2022 | Voyager Therapeutics | VYGR | Maintain | Neutral (N/A) |
|
Details | ||
| 3/1/2022 | Denali Therapeutics Inc. | DNLI | Maintain | Outperform (N/A) |
|
Details | ||
| 3/1/2022 | Ardelyx, Inc | ARDX | Maintain | Neutral (N/A) |
|
Details | ||
| 2/28/2022 | Praxis Precision Medicines Inc. | PRAX | Maintain | Outperform (N/A) |
|
Details | ||
| 2/14/2022 | Longboard Pharmaceuticals Inc | LBPH | New Coverage | Outperform (N/A) |
4.50 (59.98) |
1232.89% | Details | |
| 1/24/2022 | Karuna Therapeutics Inc. | KRTX | Maintain | Outperform (N/A) |
|
Details | ||
| 1/12/2022 | Biogen | BIIB | Maintain | Neutral (N/A) |
|
Details | ||
| 11/30/2021 | Ardelyx, Inc | ARDX | Maintain | Neutral (N/A) |
|
Details | ||
| 11/12/2021 | Chinook Therapeutics | KDNY | Maintain | Outperform (N/A) |
|
Details | ||
| 11/11/2021 | Xenon Pharmaceuticals | XENE | Maintain | Outperform (N/A) |
|
Details | ||
| 11/10/2021 | Taysha Gene Therapies | TSHA | Maintain | Outperform (N/A) |
|
Details | ||
| 11/10/2021 | Astria Therapeutics | ATXS | Maintain | Outperform (N/A) |
|
Details | ||
| 11/9/2021 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Outperform (N/A) |
|
Details | ||
| 11/9/2021 | Apellis Pharmaceuticals | APLS | Maintain | Neutral (N/A) |
|
Details | ||
| 11/8/2021 | Chinook Therapeutics | KDNY | Maintain | Outperform (N/A) |
|
Details | ||
| 11/8/2021 | Stoke Therapeutics | STOK | Maintain | Outperform (N/A) |
|
Details | ||
| 11/4/2021 | Karuna Therapeutics Inc. | KRTX | Maintain | Outperform (N/A) |
|
Details | ||
| 11/4/2021 | Passage Bio Inc. | PASG | Maintain | Outperform (N/A) |
|
Details | ||
| 11/3/2021 | Ultragenyx Pharma | RARE | Maintain | Neutral (N/A) |
|
Details | ||
| 10/20/2021 | Biogen | BIIB | Maintain | Neutral (N/A) |
|
Details | ||
| 10/13/2021 | Ardelyx, Inc | ARDX | Maintain | Neutral (N/A) |
|
Details | ||
| 10/4/2021 | Xenon Pharmaceuticals | XENE | Maintain | Outperform (N/A) |
|
Details | ||
| 9/28/2021 | Viridian Therapeutic | VRDN | Maintain | Outperform (N/A) |
|
Details | ||
| 9/10/2021 | Apellis Pharmaceuticals | APLS | Downgrade | Neutral (Outperform) |
55.61 (20.07) |
-63.91% | Details | |
| 9/3/2021 | Impel Neuropharma | IMPL | Maintain | Outperform (N/A) |
|
Details | ||
| 9/2/2021 | Catabasis | CATB | New Coverage | Outperform (N/A) |
9.41 (8.54) |
-9.25% | Details | |
| 8/19/2021 | Apellis Pharmaceuticals | APLS | Upgrade | Outperform (Neutral) |
59.02 (55.61) |
-5.78% | Details | |
| 8/16/2021 | Praxis Precision Medicines Inc. | PRAX | Maintain | Outperform (N/A) |
|
Details | ||
| 8/16/2021 | Taysha Gene Therapies | TSHA | Maintain | Outperform (N/A) |
|
Details | ||
| 8/13/2021 | Ardelyx, Inc | ARDX | Maintain | Neutral (N/A) |
|
Details | ||
| 8/5/2021 | Passage Bio Inc. | PASG | Maintain | Outperform (N/A) |
|
Details | ||
| 8/4/2021 | Neurocrine Bio. | NBIX | Maintain | Outperform (N/A) |
|
Details | ||
| 8/3/2021 | Sage Therapeutics | SAGE | Maintain | Outperform (N/A) |
|
Details | ||
| 8/3/2021 | Ultragenyx Pharma | RARE | Maintain | Neutral (N/A) |
|
Details | ||
| 7/22/2021 | Biogen | BIIB | Maintain | Neutral (N/A) |
|
Details | ||
| 7/20/2021 | Ardelyx, Inc | ARDX | Downgrade | Neutral (Outperform) |
7.70 (6.19) |
-19.61% | Details | |
| 6/9/2021 | Taysha Gene Therapies | TSHA | Maintain | Outperform (N/A) |
|
Details | ||
| 6/8/2021 | Biogen | BIIB | Maintain | Neutral (N/A) |
|
Details | ||
| 6/7/2021 | Biogen | BIIB | Maintain | Neutral (N/A) |
|
Details | ||
| 5/26/2021 | Travere Therapeutics | TVTX | Downgrade | Neutral (Outperform) |
17.75 (27.24) |
53.46% | Details | |
| 5/24/2021 | Apellis Pharmaceuticals | APLS | Maintain | Neutral (N/A) |
|
Details | ||
| 5/18/2021 | Impel Neuropharma | IMPL | New Coverage | Outperform (N/A) |
13.89 (0.24) |
-98.27% | Details | |
| 5/13/2021 | Chinook Therapeutics | KDNY | Maintain | Outperform (N/A) |
|
Details | ||
| 5/10/2021 | Stoke Therapeutics | STOK | Upgrade | Outperform (Neutral) |
32.46 (35.48) |
9.3% | Details | |
| 5/6/2021 | Neurocrine Bio. | NBIX | Maintain | Outperform (N/A) |
|
Details | ||
| 5/5/2021 | Ultragenyx Pharma | RARE | Maintain | Neutral (N/A) |
|
Details | ||
| 5/4/2021 | Sage Therapeutics | SAGE | Maintain | Outperform (N/A) |
|
Details | ||
| 5/3/2021 | Denali Therapeutics Inc. | DNLI | Maintain | Outperform (N/A) |
|
Details | ||
| 4/22/2021 | Biogen | BIIB | Maintain | Neutral (N/A) |
|
Details | ||
| 4/20/2021 | Edgewise Therapeutics | EWTX | New Coverage | Outperform (N/A) |
26.76 (27.82) |
3.96% | Details | |
| 3/25/2021 | Aptinyx | APTX | Maintain | Outperform (N/A) |
|
Details | ||
| 3/23/2021 | Ardelyx, Inc | ARDX | New Coverage | Outperform (N/A) |
6.96 (6.19) |
-11.06% | Details | |
| 3/17/2021 | Praxis Precision Medicines Inc. | PRAX | Maintain | Outperform (N/A) |
|
Details | ||
| 3/1/2021 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Outperform (N/A) |
|
Details | ||
| 2/10/2021 | Stoke Therapeutics | STOK | Downgrade | Neutral (Outperform) |
66.33 (35.48) |
-46.51% | Details | |
| 2/8/2021 | Viela Bio | VIE | Downgrade | Neutral (Outperform) |
52.85 (53.01) |
0.3% | Details | |
| 2/5/2021 | Neurocrine Bio. | NBIX | Maintain | Outperform (N/A) |
|
Details | ||
| 2/3/2021 | Biogen | BIIB | Maintain | Neutral (N/A) |
|
Details | ||
| 2/3/2021 | Voyager Therapeutics | VYGR | Downgrade | Neutral (Outperform) |
8.00 (3.90) |
-51.25% | Details | |
| 2/2/2021 | Travere Therapeutics | TVTX | Maintain | Outperform (N/A) |
|
Details | ||
| 1/29/2021 | Biogen | BIIB | Maintain | Neutral (N/A) |
|
Details | ||
| 1/29/2021 | Ultragenyx Pharma | RARE | Maintain | Neutral (N/A) |
|
Details | ||
| 1/29/2021 | Neurocrine Bio. | NBIX | Maintain | Outperform (N/A) |
|
Details | ||
| 1/29/2021 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Outperform (N/A) |
|
Details | ||
| 1/25/2021 | Passage Bio Inc. | PASG | New Coverage | Outperform (N/A) |
19.81 (8.40) |
-57.6% | Details | |
| 1/13/2021 | Acorda Therapeutics, Inc. | ACOR | Maintain | Neutral (N/A) |
|
Details | ||
| 1/6/2021 | Chinook Therapeutics | KDNY | New Coverage | Outperform (N/A) |
15.52 (40.39) |
160.24% | Details | |
| 12/23/2020 | Prevail Therapeutics | PRVL | Downgrade | Neutral (Outperform) |
23.15 (23.00) |
-0.65% | Details | |
| 12/14/2020 | Alexion Pharmaceuticals | ALXN | Downgrade | Neutral (Outperform) |
118.87 (182.01) |
53.12% | Details | |
| 12/7/2020 | Ultragenyx Pharma | RARE | Downgrade | Neutral (Outperform) |
128.53 (21.25) |
-83.47% | Details | |
| 12/1/2020 | Praxis Precision Medicines Inc. | PRAX | Maintain | Outperform (N/A) |
|
Details | ||
| 11/16/2020 | Apellis Pharmaceuticals | APLS | Maintain | Neutral (N/A) |
|
Details | ||
| 11/11/2020 | Viela Bio | VIE | Maintain | Outperform (N/A) |
|
Details | ||
| 11/10/2020 | Denali Therapeutics Inc. | DNLI | Maintain | Outperform (N/A) |
|
Details | ||
| 11/10/2020 | Voyager Therapeutics | VYGR | Maintain | Outperform (N/A) |
|
Details | ||
| 11/6/2020 | Denali Therapeutics Inc. | DNLI | Maintain | Outperform (N/A) |
|
Details | ||
| 11/6/2020 | Retrophin | RTRX | Maintain | Outperform (N/A) |
|
Details | ||
| 11/5/2020 | Karuna Therapeutics Inc. | KRTX | Maintain | Outperform (N/A) |
|
Details | ||
| 11/2/2020 | Apellis Pharmaceuticals | APLS | Maintain | Neutral (N/A) |
|
Details | ||
| 10/29/2020 | Alexion Pharmaceuticals | ALXN | Maintain | Outperform (N/A) |
|
Details | ||
| 10/28/2020 | Ultragenyx Pharma | RARE | Maintain | Outperform (N/A) |
|
Details | ||
| 10/13/2020 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Outperform (N/A) |
|
Details | ||
| 10/7/2020 | Stoke Therapeutics | STOK | Maintain | Outperform (N/A) |
|
Details | ||
| 10/7/2020 | Karuna Therapeutics Inc. | KRTX | Maintain | Outperform (N/A) |
|
Details | ||
| 9/18/2020 | Retrophin | RTRX | New Coverage | Outperform (N/A) |
19.90 (24.25) |
21.86% | Details | |
| 9/11/2020 | Sage Therapeutics | SAGE | Upgrade | Outperform (Neutral) |
54.25 (8.68) |
-84% | Details | |
| 8/13/2020 | Viela Bio | VIE | Maintain | Outperform (N/A) |
|
Details | ||
| 8/10/2020 | Sage Therapeutics | SAGE | Maintain | Neutral (N/A) |
|
Details | ||
| 8/10/2020 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Outperform (N/A) |
|
Details | ||
| 8/7/2020 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Outperform (N/A) |
|
Details | ||
| 8/6/2020 | Denali Therapeutics Inc. | DNLI | Maintain | Outperform (N/A) |
|
Details | ||
| 8/5/2020 | Karuna Therapeutics Inc. | KRTX | Maintain | Outperform (N/A) |
|
Details | ||
| 7/30/2020 | Alexion Pharmaceuticals | ALXN | Maintain | Outperform (N/A) |
|
Details | ||
| 7/22/2020 | Biogen | BIIB | Maintain | Neutral (N/A) |
|
Details | ||
| 7/1/2020 | Ultragenyx Pharma | RARE | Maintain | Outperform (N/A) |
|
Details | ||
| 6/9/2020 | Neurocrine Bio. | NBIX | New Coverage | Outperform (N/A) |
115.86 (128.13) |
10.59% | Details | |
| 6/2/2020 | Karuna Therapeutics Inc. | KRTX | Maintain | Outperform (N/A) |
|
Details | ||
| 5/26/2020 | Prevail Therapeutics | PRVL | Maintain | Outperform (N/A) |
|
Details | ||
| 5/22/2020 | Xenon Pharmaceuticals | XENE | Maintain | Outperform (N/A) |
|
Details | ||
| 5/15/2020 | Aptinyx | APTX | Maintain | Outperform (N/A) |
|
Details | ||
| 5/14/2020 | Viela Bio | VIE | Maintain | Outperform (N/A) |
|
Details | ||
| 5/8/2020 | Sage Therapeutics | SAGE | Downgrade | Neutral (Outperform) |
40.76 (8.68) |
-78.7% | Details | |
| 5/8/2020 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Outperform (N/A) |
|
Details | ||
| 5/8/2020 | Denali Therapeutics Inc. | DNLI | Maintain | Outperform (N/A) |
|
Details | ||
| 5/7/2020 | Ultragenyx Pharma | RARE | Maintain | Outperform (N/A) |
|
Details | ||
| 5/6/2020 | Voyager Therapeutics | VYGR | Maintain | Outperform (N/A) |
|
Details | ||
| 4/30/2020 | Apellis Pharmaceuticals | APLS | Maintain | Neutral (N/A) |
|
Details | ||
| 4/13/2020 | Biogen | BIIB | Maintain | Neutral (N/A) |
|
Details | ||
| 4/13/2020 | Ultragenyx Pharma | RARE | Maintain | Outperform (N/A) |
|
Details | ||
| 4/13/2020 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Outperform (N/A) |
|
Details | ||
| 4/13/2020 | Alexion Pharmaceuticals | ALXN | Maintain | Outperform (N/A) |
|
Details | ||
| 4/8/2020 | Sage Therapeutics | SAGE | Maintain | Outperform (N/A) |
|
Details | ||
| 4/6/2020 | Millendo Therapeutics Inc. | MLND | Downgrade | Neutral (Outperform) |
4.85 (1.06) |
-78.14% | Details | |
| 3/26/2020 | Prevail Therapeutics | PRVL | Maintain | Outperform (N/A) |
|
Details | ||
| 3/25/2020 | Xenon Pharmaceuticals | XENE | New Coverage | Outperform (N/A) |
10.01 (41.94) |
318.98% | Details | |
| 3/24/2020 | Karuna Therapeutics Inc. | KRTX | New Coverage | Outperform (N/A) |
71.86 (329.83) |
358.99% | Details | |
| 3/13/2020 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Outperform (N/A) |
|
Details | ||
| 3/11/2020 | Millendo Therapeutics Inc. | MLND | Maintain | Outperform (N/A) |
|
Details | ||
| 3/11/2020 | Apellis Pharmaceuticals | APLS | Upgrade | Neutral (Underperform) |
30.95 (20.07) |
-35.15% | Details | |
| 3/4/2020 | Logitech International | VTGR | Maintain | Outperform () |
|
Details | ||
| 2/28/2020 | Denali Therapeutics Inc. | DNLI | Upgrade | Outperform (N/A) |
19.02 (19.69) |
3.52% | Details | |
| 1/30/2020 | Biogen | BIIB | Maintain | Neutral (N/A) |
|
Details | ||
| 1/29/2020 | Denali Therapeutics Inc. | DNLI | Maintain | Neutral (N/A) |
|
Details | ||
| 1/29/2020 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Outperform (N/A) |
|
Details | ||
| 12/18/2019 | Stoke Therapeutics | STOK | New Coverage | Outperform (N/A) |
24.98 (35.48) |
42.03% | Details | |
| 12/5/2019 | Sage Therapeutics | SAGE | Maintain | Outperform (N/A) |
|
Details | ||
| 11/22/2019 | Apellis Pharmaceuticals | APLS | New Coverage | Underperform (N/A) |
28.70 (20.07) |
-30.07% | Details | |
| 11/22/2019 | Biohaven Pharmaceutical Holding | BHVN | New Coverage | Outperform (N/A) |
52.70 (9.92) |
-81.18% | Details | |
| 10/23/2019 | Alexion Pharmaceuticals | ALXN | Maintain | Outperform (N/A) |
|
Details | ||
| 10/22/2019 | Biogen | BIIB | Maintain | Neutral (N/A) |
|
Details | ||
| 10/16/2019 | Alexion Pharmaceuticals | ALXN | Maintain | Outperform (N/A) |
|
Details | ||
| 10/3/2019 | Dova Pharmaceuticals Inc | DOVA | Downgrade | Neutral (Outperform) |
28.23 (28.04) |
-0.67% | Details | |
| 9/26/2019 | Denali Therapeutics Inc. | DNLI | New Coverage | Neutral (N/A) |
17.44 (19.69) |
12.9% | Details | |
| 9/12/2019 | Aptinyx | APTX | New Coverage | Outperform (N/A) |
3.95 (0.06) |
-98.48% | Details | |
| 7/15/2019 | Prevail Therapeutics | PRVL | New Coverage | Outperform (N/A) |
12.13 (23.00) |
89.61% | Details | |
| 6/25/2019 | Acer Therapeutics | ACER | Maintain | Outperform (N/A) |
|
Details | ||
| 5/23/2019 | Acer Therapeutics | ACER | New Coverage | Outperform (N/A) |
19.71 (0.90) |
-95.43% | Details | |
| 5/23/2019 | Biogen | BIIB | New Coverage | Neutral (N/A) |
232.92 (184.87) |
-20.63% | Details | |
| 5/23/2019 | Acorda Therapeutics, Inc. | ACOR | New Coverage | Neutral (N/A) |
10.93 (0.66) |
-93.96% | Details | |
| 5/23/2019 | Dova Pharmaceuticals Inc | DOVA | New Coverage | Outperform (N/A) |
10.42 (28.23) |
170.92% | Details | |
| 5/23/2019 | Alexion Pharmaceuticals | ALXN | New Coverage | Outperform (N/A) |
128.80 (182.01) |
41.31% | Details | |
| 5/23/2019 | Sage Therapeutics | SAGE | New Coverage | Outperform (N/A) |
171.03 (8.68) |
-94.92% | Details |
